Article 94. Principles and competence to approve a clinical trial of a drug
Law 105/2016/QH13 — Luật Dược số 105/2016/QH13
Clinical trial of drugs
1. A clinical trial of a drug shall be conducted only after the dossier of the trial has been assessed in terms of scientific and ethical issues by the National Council of Ethics in Biomedical Research and the trial is approved in writing by the Minister of Health.
2. The clinical trial of a drug, scientific and ethical assessment of the dossier of the clinical trial, and approval of the clinical trial must adhere to the following principles:
a/ Respecting the right to self-determination of participants in the trial and protecting the persons who have their right to self-determination restricted;
b/ Ensuring that the research benefits outweigh risks and that the risks in the research are carefully considered and minimized according to standards;
c/ Ensuring equality in benefits and responsibilities and fair distribution of benefits and risks among participants in the trial;
d/ Strictly following the stages of clinical trial and applying good practices in clinical trial.
3. The council of ethics in biomedical research is an independent body established at the national level or at the establishment’s level to protect the rights, safety and health of participants in the trial of a drug.
The Minister of Health shall stipulate the establishment, functions, tasks and powers of a council of ethics in biomedical research.
Article 94, Law 105/2016/QH13